RYCEF:OTO-RollsRoyce Holdings Plc (USD)

COMMON STOCK | Aerospace & Defense | OTC Pink

Last Closing

USD 7.19

Change

+0.14 (+1.99)%

Market Cap

USD 16.60B

Volume

0.07M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Rolls-Royce Holdings PLC manufactures aero, marine and industrial gas turbines for civil & military aircraft. It designs, constructs, supplies and installs power generation systems, transmission and distribution systems and equipment for defence markets.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-02 )

Largest Industry Peers for Aerospace & Defense

Symbol Name Price(Change) Market Cap
EADSY Airbus Group NV

N/A

USD 132.55B
SAFRF Safran SA

N/A

USD 91.20B
RLLCF Rolls-Royce Holdings plc

N/A

USD 74.12B
RYCEY Rolls Royce Holdings plc

N/A

USD 62.51B
BAESY BAE Systems PLC

N/A

USD 46.65B
THLEF Thales S.A

N/A

USD 29.95B
THLLY Thales SA ADR

N/A

USD 29.62B
RNMBF Rheinmetall AG

N/A

USD 28.25B
DUAVF Dassault Aviation SA

N/A

USD 16.12B
FINMF Leonardo S.p.a

N/A

USD 16.02B

ETFs Containing RYCEF

N/A

Market Performance

  Market Performance vs. Industry/Classification (Aerospace & Defense) Market Performance vs. Exchange (OTC Pink)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.99% 64% D 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.99% 64% D 62% D
Trailing 12 Months  
Capital Gain 90.72% 86% B+ 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 90.72% 86% B+ 90% A-
Trailing 5 Years  
Capital Gain -19.66% 39% F 56% F
Dividend Return 0.79% 3% F 2% F
Total Return -18.87% 37% F 49% F
Average Annual (5 Year Horizon)  
Capital Gain 52.18% 77% C+ 77% C+
Dividend Return 52.18% 77% C+ 75% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 104.03% 26% F 34% F
Risk Adjusted Return 50.16% 64% D 84% B
Market Capitalization 16.60B 93% A 98% N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Dividend Growth

This stock has shown top quartile dividend growth in the previous 5 years compared to its sector

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Negative earnings

The company had negative total earnings in the most recent four quarters.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector